Panel-based pharmacogenetic genotyping for Pharmacogenetic Testing
This trial will test whether panel-based pharmacogenetic testing leads to improved medication satisfaction for black and Latino patients.
1 Primary · 0 Secondary · Reporting Duration: 12-14 months
1 Treatment Group
Panel-based pharmacogenetic genotyping
1 of 1
100 Total Participants · 1 Treatment Group
Primary Treatment: Panel-based pharmacogenetic genotyping · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 99 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the uppermost limit for participant enrollment in this clinical experiment?
"That is correct. Clinicaltrials.gov notes that this clinical trial, which was initially posted on May 13th 2021, is actively enrolling participants. This study requires 100 people to join from a single medical centre." - Anonymous Online Contributor
Does my profile qualify me to participate in this investigation?
"This research trial is open to 100 individuals aged 18-99 with a recent pharmacogenetic test. Other inclusion requirements include: evidence of medication adjustment within the past 6 months, and self-identifying as either Black or Latinx." - Anonymous Online Contributor
Are new participants still being accepted into this research?
"Affirmative. Clinicaltrials.gov confirms that recruitment is open for this medical project, which was first posted on May 13th 2021 and has since been revised on June 28th 2022. The trial seeks 100 applicants from one particular clinical site." - Anonymous Online Contributor
Does the study accept participants younger than 80 years of age?
"In order to be accepted into this clinical trial, individuals must meet the age requirements. These are a minimum of 18 years and a maximum of 99 years old." - Anonymous Online Contributor